Smith Hunter C bought RYTM

May 18, 2026 · Form 4 insider transaction

Smith Hunter C bought 3,000 shares of Rhythm Pharmaceuticals, Inc. at $17.87 per share, a transaction worth $53.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.